王晓露1 解方为2 陈曦2 张霞2 欧阳学农2.丹参酮IIA 对大鼠移植性肝癌的抑制作用[J].现代生物医学进展英文版,2011,11(11):2062-2064. |
丹参酮IIA 对大鼠移植性肝癌的抑制作用 |
The Inhibitive Effect of Tanshinone IIA on Implanted Hepatoma in Rats |
|
DOI: |
中文关键词: 丹参酮IIA HMGB1 VEGF |
英文关键词: Tanshinone IIA HMGB1 VEGF |
基金项目:" 十一五" 军队中医药研发推广专项课题基金资助(2006051002) |
|
Hits: 535 |
Download times: 814 |
中文摘要: |
目的:观察丹参酮IIA 对大鼠移植性肝癌的抑制作用。方法:将SD 大鼠随机分为假手术组、模型组、丹参酮IIA 高、低剂量
组。各组动物于移植术后12d 处死。分离肿瘤测量其体积,realtime RT-PCR 法和western blot 法检测肿瘤组织中HMGB1、VEGF
mRNA 和蛋白的表达。结果:丹参酮IIA 能明显降低肿瘤体积,降低肿瘤组织中HMGB1、VEGF mRNA 和蛋白的表达。结论:丹参
酮IIA 能抑制大鼠移植性肝癌的生长,其机制可能与抑制HMGB1、VEGF 表达有关。 |
英文摘要: |
Objective: To study the effect of Tanshinone IIA on implanted hepatoma in rats. Method: Sprague Dawley rats were
divide into normal group, sham operated group and two Tanshinone IIA groups. Contents of HMGB1, VEGF protein and mRNA were
detected by immunohistochemical and real-time PCR methods, respectivly. Result: In Tanshinone IIA groups, Contents of HMGB1,
VEGF protein and mRNA were decreased markedly. Conclusion: Tanshinone IIA could inhibit the implanted hepatoma in rats. This
maybe be concerned with that it could inhibit the expression of HMGB1 and VEGF in the implanted hepatoma in rats. |
View Full Text
View/Add Comment Download reader |
Close |